ONSD modifications induced by arterial paCO₂ changes. by Marco Carbonara (11483575)

Table 1 - by Marco Carbonara (11483575)

Observed whooper swan behaviour at different times of day. by Kevin A. Wood (7879820)

Observed mute swan behaviour at different times of day. by Kevin A. Wood (7879820)

Two Polymorphic Polyoxometalate-Based Metal–Organic Frameworks for the Efficient Synthesis of Functionalized Sulfoxides and Detoxification of Mustard Gas Simulants by Yanhong Chen (304926)

“…Simultaneously, both <b>1-α</b> and <b>1-β</b> showed an extraordinary degradation efficiency of 2-chloroethyl ethyl sulfide and have a half lifetime (<i>t</i>_1/2) approximately 2.5 or 3 min, respectively, with 100% selectivity toward the nontoxic product 2-chloroethyl ethyl sulfoxide and an abnormally high oxidant utilization efficiency (94.5% for <b>1-α</b> and 94.3% for <b>1-β</b>) at room temperature. …”

Complexity for all neighborhoods and rp values performed, with <i>ω</i>^(<i>k</i>) = 5 and <i>N</i> = 100. by Gabriel Moreno Cunha (20390408)

Deep reinforcement learning agents trained using a curriculum solve navigation tasks with delayed rewards. by William L. Tong (22238845)

Examples of the evolutionary simulation that showed hourglass-like developmental correlation. by Takahiro Kohsokabe (18078713)

SHAP Tree explainer for (a) Model 1: Presentation and (b) Model 6: Closures. by Nathan C. Hurley (10510304)

“…Red values indicate high values for that variable (if continuous or ordinal) or “true” (if binary), while blue values indicate the opposite. Points to the right of the axis (positive SHAP values) indicate that a feature of that value increases model estimate of bleeding risk, while points to the left of the axis (negative SHAP values) indicate that a feature of that value decreases the model estimate of bleeding risk. …”

PRISMA flow diagram. by Apoorva Anand (17921197)

“…Lower sensitivity was attributed to absence of symptoms, errors in test conduct and absence of supervision or a digital support. We found no difference in COVIDST sensitivity between delta and omicron pre-dominant period. …”

Meta-analyses of COVIDST diagnostic accuracy. by Apoorva Anand (17921197)

“…Lower sensitivity was attributed to absence of symptoms, errors in test conduct and absence of supervision or a digital support. We found no difference in COVIDST sensitivity between delta and omicron pre-dominant period. …”

Effect of NNC on Aβ_1–42 uptake. by Joseph Schober (4591696)

IL-18 increases paracellular permeability when applied to the apical surface. by Ossama Allam (5043434)

DataSheet_1_Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.docx by Nebojsa Skorupan (12522600)

“…Background<p>LMB-100 is a mesothelin (MSLN)-targeting recombinant immunotoxin (iTox) carrying a Pseudomonas exotoxin A payload that has shown promise against solid tumors, however, efficacy is limited by the development of neutralizing anti-drug antibodies (ADAs). …”

DataSheet_2_Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.xlsx by Nebojsa Skorupan (12522600)

“…Background<p>LMB-100 is a mesothelin (MSLN)-targeting recombinant immunotoxin (iTox) carrying a Pseudomonas exotoxin A payload that has shown promise against solid tumors, however, efficacy is limited by the development of neutralizing anti-drug antibodies (ADAs). …”

Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i> by Vidya G. Bettada (22208808)

“…Mouse EAC cells showed a decrease in cell viability starting from 250 µM at 24h of treatment. …”

A conceptual figure representing the baroreflex equilibrium diagram analysis. by Aimi Yokoi (16819464)

Expression of <i>Nars2</i> in mouse inner ear and brain. by Mariella Simon (711384)

Demographics of included study participants with lung clearance index (LCI) and pulmonary function data (mean ± standard deviation). For corrector/potentiators in CF group, I = iva... by Monica E. Shapiro (22622240)

Timeline of the prospective study protocol. by Alexander Runkel (17319586)

“…Thus, the participation and support of a wider group of oncologic surgeons are needed to validate these findings on a larger patient cohort.…”